top of page

VitaTalk Ep. 13

Revolutionizing Sterilization: Breaking the Bottleneck with IQVHP

In Episode 13 of the VitaTalk Podcast, host Patrick Hodgdon (VP of Marketing), CEO Jason Scherer, and special guest Dave Bell of Sterilucent dive deep into the future of sterilization technology. From decades of entrepreneurial insight to a bold reimagining of how sterilization is approached in the medical and military arenas, this conversation is a must-listen for innovators in medtech.


The Sterilization Crisis: A Persistent Bottleneck Sterilization has long plagued medtech companies with inefficiencies, high costs, and slow throughput. With increasing regulatory scrutiny from EPA, OSHA, and FDA, existing ethylene oxide (ETO) systems must now meet tighter safety standards, requiring lower emissions and chamber-contained sterilization and aeration. This has only added pressure to an already overburdened process.


Enter Dave Bell: Disruptor and Inventor Dave Bell, a Minnesota-based entrepreneur and founder of Phygen and now Sterilucent, has spent his career commercializing disruptive technologies. From introducing photo finishing to Walmart to launching surface enhancement tech globally, Bell has a history of turning niche technologies into mainstream solutions. His latest mission: bringing intelligent, gentle sterilization to the forefront of medical innovation.


From Soviet Science to Modern Medical Marvels Bell's journey to IQVHP (Intelligent Vaporized Hydrogen Peroxide) began with a deep dive into plasma acceleration technology from Ukraine, eventually pivoting into healthcare. With backing from the U.S. Army and other partners, Bell's team developed a sterilization system that is fast, effective, and safe, with minimal emissions and high compatibility with delicate medical instruments.


Why IQVHP Is the iPhone of Sterilization Bell draws a compelling analogy: traditional sterilization methods are like Blackberries, and IQVHP is the iPhone. Unlike harsh legacy systems, IQVHP is designed for today's high-performance medical devices. Key differentiators include:

  • Material Compatibility: Twice the compatibility of leading VHP systems

  • Efficiency: 30- to 60-minute cycles

  • Smart Dosing: Tailored hydrogen peroxide levels for each load

  • Cost-Effectiveness: Comparable or better than conventional systems

  • Eco-Safety: Converts peroxide into water and oxygen, requiring no venting


Engineering with Reuse in Mind By enabling gentle sterilization, IQVHP allows medical device designers to use advanced materials without worrying about degradation. This opens the door to reusable instruments, reducing cost per procedure and enabling broader access to high-end tools.


Built for Agility and Speed Unlike traditional sterilization providers, Sterilucent brings startup agility to the table. Their on-site ISO lab allows them to turn around sterilization validations in days, not weeks, providing unparalleled speed for developers under tight deadlines.


Transparent Costs and Real Value Dave Bell challenges the medtech community to rethink cost. Most don’t know the true cost of sterilization, factoring in repairs, downtime, shipping, and equipment wear. IQVHP offers lifecycle savings through reduced instrument damage, faster processing, and less infrastructure.


Disrupting a Duopoly With just a few large players dominating the hydrogen peroxide sterilization space, innovation has stagnated. Sterilucent breaks that mold by focusing on customer-centric design, flexible deployment (including point-of-use sterilization), and a mission to democratize access to safer, smarter solutions.


What’s Next? As Sterilucent prepares its FDA 510(k) submission, it invites innovators, especially catheter manufacturers and device developers, to collaborate. The technology is ready. The infrastructure is in place. Now it’s about scaling smart partnerships.


Final Thoughts This episode of VitaTalk uncovers how thoughtful engineering, disruptive vision, and patient-centered innovation can reshape an industry. If you're building next-gen devices and want sterilization that keeps pace, it might be time to rethink what "standard" means.

Learn more at sterilucent.com or contact Dave directly at dave.bell@sterilucent.com.


Share & follow


For any inquiries, please contact: vitatek.io/contact

 
 
 

Comentários


3469 Lake Elmo Ave N, #304

Lake Elmo, MN 55042

(612) 500-7433

FOLLOW US

LinkedIn

Instagram

Facebook

VitaTek is an innovative, one-stop medical device development incubator, accelerator and manufacturing company that specializes in bringing ideas to market. We are dedicated to commercializing medical devices and providing innovative solutions to the healthcare industry that make a difference in people's lives. We work worldwide with clinicians, inventors and start-up medical device companies to bring patented, or simply ‘napkin-sketched’ medical device ideas to life. Our services include ideation conceptualization, research and development, prototyping, FDA compliance and regulatory services, usability testing and validation, 510k submissions, tool & die molds, manufacturing, hydrophilic coating, sterilization, warehousing, distribution, marketing and sales.

© 2025 VitaTek. ISO 13485 Compliant.

bottom of page